| PRL3-Zumab in Patients With Advanced Solid Tumors (NCT07541001) | Intra-IMMUSG Pte Ltd | 2021-08-30 |
| Naldebain for Pain Management of Laparoscopic Cholecystectomy (NCT04808544) | E-DA Hospital | 2021-08-30 |
| CBD for the Treatment of Alcohol Use Disorder (NCT04873453) | University of Colorado, Denver | 2021-08-30 |
| Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC (NCT05055167) | The First Affiliated Hospital of Xiamen University | 2021-08-30 |
| Radioprotective Effect of Chinese Herbal Medicine on Oral Mucositis (NCT05040425) | Chang Gung Memorial Hospital | 2021-08-30 |
| R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL (NCT04992377) | Institute of Hematology & Blood Diseases Hospital, China | 2021-08-30 |
| The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study (NCT04818034) | University of California, San Francisco | 2021-08-30 |
| PPMI Tau PET Imaging (NCT04906590) | Michael J. Fox Foundation for Parkinson's Research | 2021-08-30 |
| Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors (NCT04974957) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2021-08-30 |
| Vedolizumab for Immune Mediated Colitis (NCT04797325) | University of Copenhagen | 2021-08-30 |
| A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) (NCT04765384) | Janssen Vaccines & Prevention B.V. | 2021-08-27 |
| Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled Trial (NCT04971005) | Universitätsklinikum Hamburg-Eppendorf | 2021-08-27 |
| Study of JS004 Combined With Toripalimab for Advanced Lung Cancer (NCT05000684) | Shanghai Junshi Bioscience Co., Ltd. | 2021-08-27 |
| Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT04956042) | CicloMed LLC | 2021-08-27 |
| A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA) (NCT04814368) | Novartis Pharmaceuticals | 2021-08-27 |
| A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. (NCT05063734) | Oxurion | 2021-08-27 |
| Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients (NCT04880382) | Institut Bergonié | 2021-08-27 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| A Long-term Extension of Study GNC-401 (NCT05049161) | GeNeuro Innovation SAS | 2021-08-27 |
| Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC (NCT04811027) | Immutep S.A.S. | 2021-08-27 |
| Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury (NCT04683848) | Tanabe Pharma America, Inc. | 2021-08-27 |
| SPI-1005 Treatment in Severe COVID-19 Patients (NCT04483973) | Sound Pharmaceuticals, Incorporated | 2021-08-27 |
| Targeting IL-17A for Treatment-Resistant Depression (NCT04979910) | Icahn School of Medicine at Mount Sinai | 2021-08-27 |
| The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA (NCT05005637) | Fakultas Kedokteran Universitas Indonesia | 2021-08-27 |
| Sintilimab in Cancer of Unknown Primary (NCT05024968) | M.D. Anderson Cancer Center | 2021-08-26 |
| Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma (NCT04849260) | Lee's Pharmaceutical Limited | 2021-08-26 |
| Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers (NCT05010928) | Chang Gung Memorial Hospital | 2021-08-26 |
| Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study (NCT04409795) | Joslin Diabetes Center | 2021-08-26 |
| Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial (NCT04714710) | Pr. Nicolas GIRERD | 2021-08-26 |
| Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study. (NCT05027386) | Sun Yat-sen University | 2021-08-26 |
| Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT04905407) | Syros Pharmaceuticals | 2021-08-26 |
| Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19 (NCT04884295) | ExeVir Bio BV | 2021-08-26 |
| Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment (NCT04875611) | Maria Sklodowska-Curie National Research Institute of Oncology | 2021-08-26 |
| A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT04968574) | Endeavor Biomedicines, Inc. | 2021-08-26 |
| Study to Evaluate Primaquine for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in Children (NCT05044637) | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 2021-08-26 |
| Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants (NCT05004181) | BioNTech SE | 2021-08-25 |
| Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers (NCT04911660) | Insel Gruppe AG, University Hospital Bern | 2021-08-25 |
| A Study of CC-99677 in Participants With Active Ankylosing Spondylitis (NCT04947579) | Celgene | 2021-08-25 |
| Tazemetostat in Malignant Peripheral Nerve Sheath Tumors (NCT04917042) | University of Florida | 2021-08-25 |
| PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study (NCT04819243) | Samsung Medical Center | 2021-08-25 |
| Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). (NCT05011513) | Pfizer | 2021-08-25 |
| Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer (NCT05025735) | Saint Luke's Health System | 2021-08-25 |
| NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma (NCT04851834) | Xennials Therapeutics Australia Pty Ltd | 2021-08-25 |
| FL-101 in Surgically Resectable Non-Small Cell Lung Cancer (NCT04758949) | Flame Biosciences | 2021-08-25 |
| ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis (NCT04795141) | Inmagene LLC | 2021-08-24 |
| Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19 (NCT04911777) | SyneuRx International (Taiwan) Corp | 2021-08-24 |
| Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer (NCT04807166) | Wenjun Cheng | 2021-08-24 |
| Capsaicin for Post-stroke Dysphagia (NCT04470752) | Georg Kägi, MD | 2021-08-24 |
| Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma (NCT04331041) | Washington University School of Medicine | 2021-08-24 |
| Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer (NCT04805788) | Mayo Clinic | 2021-08-24 |
| Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma (NCT04301778) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-08-24 |
| Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers (NCT04946968) | National Cancer Centre, Singapore | 2021-08-24 |
| Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer (NCT05010681) | Fudan University | 2021-08-24 |
| Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant (NCT04836390) | Michael Pulsipher | 2021-08-24 |
| Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (NCT04849364) | Bryan Schneider, MD | 2021-08-24 |
| Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects (NCT04909450) | Claris Biotherapeutics, Inc. | 2021-08-24 |
| A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial (NCT04876391) | Boehringer Ingelheim | 2021-08-24 |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma (NCT05010668) | Fudan University | 2021-08-24 |
| Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy (NCT05004129) | AMO Pharma Limited | 2021-08-23 |
| Suvorexant to Reduce Symptoms of Nicotine Use (NCT04234997) | The University of Texas Health Science Center, Houston | 2021-08-23 |
| Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children (NCT04724252) | University of California, Davis | 2021-08-23 |
| Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention (NCT04843046) | The University of Texas Health Science Center, Houston | 2021-08-23 |
| A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (NCT05019521) | Alexion Pharmaceuticals, Inc. | 2021-08-23 |
| The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE) (NCT04948034) | Fudan University | 2021-08-23 |
| Vigabatrin and Insulin Sensitivity (NCT04321395) | Washington University School of Medicine | 2021-08-23 |
| A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (NCT04982276) | Akeso | 2021-08-23 |
| Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease (NCT06247410) | SocraTec R&D GmbH | 2021-08-23 |
| Safety/Immunogenicity Hantaan Virus DNA Vaccine and Puumala Virus DNA Vaccine, For Prevention of HFRS (NCT04333459) | U.S. Army Medical Research and Development Command | 2021-08-23 |
| Acalabrutinib in CNSL (NCT04906902) | Dana-Farber Cancer Institute | 2021-08-23 |
| Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study (NCT05026736) | M.D. Anderson Cancer Center | 2021-08-23 |
| Investigator-initiated Clinical Trial of MIKE-1 (NCT05064618) | Nagoya University | 2021-08-23 |
| Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19 (NCT04860518) | Faron Pharmaceuticals Ltd | 2021-08-23 |
| HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden. (NCT04898504) | Oslo University Hospital | 2021-08-23 |
| The University of Michigan OWL (Online Wellness and Lifestyle) Study (NCT05010083) | University of Michigan | 2021-08-23 |
| A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer (NCT05068024) | Forward Pharmaceuticals Co., Ltd. | 2021-08-23 |
| Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia (NCT05045443) | Ain Shams University | 2021-08-22 |
| Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression (NCT05018013) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-08-21 |
| A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP (NCT05023915) | Shandong University | 2021-08-21 |
| Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy (NCT04970121) | Yan Yang, MD, Ph.D | 2021-08-21 |
| An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese (NCT05245994) | Li Zhang, MD | 2021-08-21 |
| Effect of Vitamin D Oral Supplementation in Poly Csytic Ovarian Women Resistant to Clomiphene Citrate (NCT04916925) | rana alaaeldin aly ibrahim nasr | 2021-08-21 |
| Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery (NCT05024019) | Eye & ENT Hospital of Fudan University | 2021-08-21 |
| A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus (NCT04882878) | Janssen Research & Development, LLC | 2021-08-20 |
| Efficacy Evaluation of Shen Cao Gan Jiang Tang on Mild and Moderate COVID-19 Patients (NCT05055427) | University of Medicine and Pharmacy at Ho Chi Minh City | 2021-08-20 |
| Cannabinoids in PLWHIV on Effective ART (NCT03550352) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2021-08-20 |
| TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC (NCT04992143) | First Affiliated Hospital of Zhejiang University | 2021-08-20 |
| Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT) (NCT04999592) | David J. Gagnon | 2021-08-20 |
| Treatment of Post-bariatric Hypoglycaemia (NCT04836273) | Filip Krag Knop | 2021-08-20 |
| A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCC (NCT04948697) | BeiGene | 2021-08-20 |
| Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC (NCT04943029) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-08-20 |
| Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens (NCT04989816) | AstraZeneca | 2021-08-20 |
| Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib (NCT05020964) | Chinese Academy of Medical Sciences | 2021-08-20 |
| Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma (NCT04995016) | Tianjin Medical University Second Hospital | 2021-08-20 |
| Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases (NCT06611657) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-08-20 |
| Abemaciclib With or Without Atezolizumab for mCRPC (NCT04751929) | Dana-Farber Cancer Institute | 2021-08-20 |
| Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98) (NCT04938817) | Merck Sharp & Dohme LLC | 2021-08-19 |
| Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements (NCT05175235) | National University Hospital, Singapore | 2021-08-19 |
| Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment (NCT04557956) | National Cancer Institute (NCI) | 2021-08-19 |
| Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures (NCT04897750) | Cessatech A/S | 2021-08-19 |
| ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects (NCT05077267) | Bavarian Nordic | 2021-08-19 |